thimerosal has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tatarintsev, AV; Varfolomeyev, SD; Vrzheshch, PV; Yershov, DE | 1 |
Hayashi, M; Imai, Y; Naraba, H; Oh-ishi, S | 1 |
Imai, Y; Kudo, I; Nakagawa, Y; Naraba, H; Oh-ishi, S | 1 |
Feijge, MA; Heemskerk, JW; Keularts, IM; van Gorp, RM; Vuist, WM | 1 |
4 other study(ies) available for thimerosal and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Calcimycin; Epinephrine; Humans; Kinetics; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Tetradecanoylphorbol Acetate; Thimerosal | 1992 |
Enhanced production of platelet-activating factor in stimulated rat leukocytes caused by the blockade of lysophospholipid acylation.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acylation; Animals; Blood Platelets; Humans; In Vitro Techniques; Leukocytes; Lysophospholipids; Macrophages; Male; Neutrophils; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Thimerosal; Triazenes; Vasodilator Agents; Zymosan | 1993 |
Activation of phospholipase A2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils.
Topics: Acylation; Animals; Antibodies, Monoclonal; Arachidonic Acid; Enzyme Activation; Lysophospholipids; Male; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thimerosal; Triazenes; Zymosan | 1995 |
alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels.
Topics: Adrenergic alpha-Agonists; Aspirin; Blood Platelets; Brimonidine Tartrate; Calcium; Calcium Chloride; Carbazoles; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Epinephrine; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Models, Biological; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandins E; Pyrroles; Quinoxalines; Receptors, Adrenergic, alpha-2; Stimulation, Chemical; Thapsigargin; Thimerosal; Thrombin; Time Factors | 2000 |